Sign in
AIDX Stock Price, Chart, Stats & News
20/20 Biolabs Inc.
Save
20/20 Biolabs Inc. (AIDX) does not currently pay a dividend.
3.11M
Market cap
–
Current P/E
–
Forward P/E
AIDX chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 32.29% |
Operating margin | -214.26% |
Pretax margin | -217.45% |
Net margin | -217.45% |
Effective tax rate | – |
ROA | -64.04% |
ROE | -252.59% |
D/E | 15.64x |
Interest coverage ratio | -69.18x |
AIDX valuation
P/E | – |
P/S | 9.27x |
P/B | 80.59x |
P/CF | -16.29x |
P/FCF | -16.49x |
P/OCF | -16.29x |
PEG | -0.04x |
EV multiple | -4.15x |
About
20/20 GeneSystems, Inc. operates as a clinical laboratory testing company focused on cancer screening and viral testing services. The company provides multi-cancer early detection blood testing, including a test called OneTest, and offers viral testing services such as rapid COVID-19 test kits, including the Assure COVID-19 IgG/IgM rapid test. It operates the Clinical Lab Innovation Axcelerator (CLIAx), a shared laboratory facility that supports diagnostic test developers in bringing products to the U.
Similar securities
Based on sector and market capitalization
Report issue